A comprehensive view of Eli Lilly & Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Eli Lilly and Company Seeks Patent for Extended Time Action Acylated Insulin Compounds
Published: March 25, 2023 by Pharmaceutical Patent News
Australia: Eli Lilly and Co. Receives Patent for 'An Aurora A kinase inhibitor for use in the treatment of neuroblastoma'
Published: March 24, 2023 by Australian Government
Australia: Eli Lilly and Co. Receives Patent for 'Methods of determining protein or peptide concentration and uses thereof'
Published: March 24, 2023 by Australian Government
Roche partners with Eli Lilly to support development of Roche’s Elecsys Amyloid Plasma Panel blood test to facilitate earlier diagnosis of Alzheimer’s disease; about 75% of people showing symptoms of Alzheimer’s globally do not have a diagnosis
Published: March 23, 2023 by Marketline - Deals
Supporters of People for the Ethical Treatment of Animals confront Eli Lilly CEO during speech at Adobe Summit in Venice about animal test used by Lilly in depression studies; ‘forced swimming’ test has been banned by other pharma companies
Published: March 22, 2023 by States News Service

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count